RhumbLine Advisers’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-64,945
| Closed | -$1.3M | – | 3076 |
|
|
2022
Q3 | $1.3M | Buy |
64,945
+6,213
| +11% | +$124K | ﹤0.01% | 2004 |
|
|
2022
Q2 | $405K | Buy |
58,732
+15,182
| +35% | +$105K | ﹤0.01% | 2606 |
|
|
2022
Q1 | $405K | Sell |
43,550
-1,373
| -3% | -$12.8K | ﹤0.01% | 2515 |
|
|
2021
Q4 | $639K | Buy |
44,923
+532
| +1% | +$7.57K | ﹤0.01% | 2409 |
|
|
2021
Q3 | $1.03M | Buy |
44,391
+1,875
| +4% | +$43.5K | ﹤0.01% | 2218 |
|
|
2021
Q2 | $1.06M | Buy |
42,516
+11,176
| +36% | +$278K | ﹤0.01% | 2219 |
|
|
2021
Q1 | $878K | Buy |
31,340
+11,506
| +58% | +$322K | ﹤0.01% | 2243 |
|
|
2020
Q4 | $692K | Buy |
19,834
+2,201
| +12% | +$76.8K | ﹤0.01% | 2306 |
|
|
2020
Q3 | $879K | Buy |
+17,633
| New | +$879K | ﹤0.01% | 2043 |
|